Fig. 3: The outline of the mechanisms by which MTs prevent DCM.
From: New insights into the role of metallothioneins in obesity and diabetes
Ang II refers to angiotensin II, AGEs to advanced glycation end-products, ALX to receptor A lipoxin, DCM to diabetic cardiomyopathy, ER to endoplasmic reticulum, NF-κB to nuclear factor kappa-light-chain-enhancer of activated B cells, ROS to reactive oxygen species, and STZ to streptozotocin.
